Ann Rheum Dis:基于血清的可溶性标记物可以区分银屑病关节炎和骨关节炎

2019-03-26 xiangting MedSci原创

一组共4个生物标志物可以区分PsA和OA。

这项研究旨在确定可区分银屑病关节炎(PsA)和骨关节炎(OA)的可溶性生物标志物。

比较了201例OA患者、77名PsA患者和76名对照血清样本中的软骨代谢(软骨低聚基质蛋白[COMP]、透明质酸)、代谢综合征(脂联素、降脂蛋白、抵抗素、肝细胞生长因子[HGF]、胰岛素、瘦素)和炎症的标志物(C-反应蛋白[CRP]、白介素-1β[IL-1β]、IL-6、IL-8、肿瘤坏死因子α[TNFα]、单核细胞趋化蛋白-1 [MCP-1]、神经生长因子[NGF])。使用Kruskal-Wallis检验比较各组的水平。使用Wilcoxon秩和检验进行成对比较。进行多因素logistic回归分析以识别可以区分PsA与OA的标志物。基于多因素模型构建受试者操作特征(ROC)曲线。使用年龄、性别和生物标志物系数计算的预测概率,在一组独立的73名PsA患者和75名OA患者样本中进一步验证最终模型。

以下标志物水平在3组间存在显著差异(p<0.001)-COMP、透明质酸、抵抗素、HGF、胰岛素、瘦素、CRP、IL-6、IL-8、TNFα、MCP-1、NGF。在多因素分析中,与OA比较,COMP(OR 1.24,95%CI 1.06-1.46)、抵抗素(OR 1.26,95%CI 1.07-1.48)、MCP-1(OR 1.10,95%CI 0.07-1.48)和NGF(OR<0.001,95%CI<0.001-0.25)被发现与PsA独立相关。与仅使用年龄和性别的模型相比(AUROC 0.87,p<0.001),该模型的ROC曲线下面积(AUROC)为0.99。使用验证样本的结果类似。

一组共4个生物标志物可以区分PsA和OA。这些结果需要在前瞻性研究中进行进一步验证。

原始出处:

Vinod Chandran. Serum-based soluble markers differentiate psoriatic arthritis from osteoarthritis. Ann Rheum Dis. 25 March 2019.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2012976, encodeId=b03d20129e670, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Dec 19 21:34:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904522, encodeId=e01319045225b, content=<a href='/topic/show?id=b8aa619690e' target=_blank style='color:#2F92EE;'>#标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61969, encryptionId=b8aa619690e, topicName=标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Thu Sep 12 23:34:00 CST 2019, time=2019-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026621, encodeId=5811202662156, content=<a href='/topic/show?id=e0b110159578' target=_blank style='color:#2F92EE;'>#骨关节#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101595, encryptionId=e0b110159578, topicName=骨关节)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373b263, createdName=lisa438, createdTime=Fri Nov 08 16:34:00 CST 2019, time=2019-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265938, encodeId=198012659385b, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Thu Mar 28 00:34:00 CST 2019, time=2019-03-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2012976, encodeId=b03d20129e670, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Dec 19 21:34:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904522, encodeId=e01319045225b, content=<a href='/topic/show?id=b8aa619690e' target=_blank style='color:#2F92EE;'>#标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61969, encryptionId=b8aa619690e, topicName=标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Thu Sep 12 23:34:00 CST 2019, time=2019-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026621, encodeId=5811202662156, content=<a href='/topic/show?id=e0b110159578' target=_blank style='color:#2F92EE;'>#骨关节#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101595, encryptionId=e0b110159578, topicName=骨关节)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373b263, createdName=lisa438, createdTime=Fri Nov 08 16:34:00 CST 2019, time=2019-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265938, encodeId=198012659385b, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Thu Mar 28 00:34:00 CST 2019, time=2019-03-28, status=1, ipAttribution=)]
    2019-09-12 wjywjy
  3. [GetPortalCommentsPageByObjectIdResponse(id=2012976, encodeId=b03d20129e670, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Dec 19 21:34:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904522, encodeId=e01319045225b, content=<a href='/topic/show?id=b8aa619690e' target=_blank style='color:#2F92EE;'>#标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61969, encryptionId=b8aa619690e, topicName=标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Thu Sep 12 23:34:00 CST 2019, time=2019-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026621, encodeId=5811202662156, content=<a href='/topic/show?id=e0b110159578' target=_blank style='color:#2F92EE;'>#骨关节#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101595, encryptionId=e0b110159578, topicName=骨关节)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373b263, createdName=lisa438, createdTime=Fri Nov 08 16:34:00 CST 2019, time=2019-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265938, encodeId=198012659385b, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Thu Mar 28 00:34:00 CST 2019, time=2019-03-28, status=1, ipAttribution=)]
    2019-11-08 lisa438
  4. [GetPortalCommentsPageByObjectIdResponse(id=2012976, encodeId=b03d20129e670, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Dec 19 21:34:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904522, encodeId=e01319045225b, content=<a href='/topic/show?id=b8aa619690e' target=_blank style='color:#2F92EE;'>#标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61969, encryptionId=b8aa619690e, topicName=标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1072181, createdName=wjywjy, createdTime=Thu Sep 12 23:34:00 CST 2019, time=2019-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2026621, encodeId=5811202662156, content=<a href='/topic/show?id=e0b110159578' target=_blank style='color:#2F92EE;'>#骨关节#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101595, encryptionId=e0b110159578, topicName=骨关节)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373b263, createdName=lisa438, createdTime=Fri Nov 08 16:34:00 CST 2019, time=2019-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1265938, encodeId=198012659385b, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Thu Mar 28 00:34:00 CST 2019, time=2019-03-28, status=1, ipAttribution=)]
    2019-03-28 lmm397

相关资讯

Ann Rheum Dis:银屑病关节炎中滑膜组织多功能T细胞与DAPSA的关联

这些数据证明,PsA滑膜组织中多功能T细胞的富集与DAPSA和离体治疗反应密切相关。

J Rheumatol:银屑病关节炎患者使用TNFi达到缓解的预测因子

根据CDAI标准,基于美国的登记中少数PsA患者达到缓解。女性、肥胖、合并症和教育程度对使用TNFi能否达到缓解有影响。

J Rheumatol:银屑病关节炎患者的负担和疾病特征

不同严重程度PsA患者的疾病负担都很明显。相当一部分PsA患者未接受过抗银屑病治疗。

Arthritis Rheumatol:依那西普和甲氨蝶呤单药或联合用药治疗银屑病关节炎的疗效

联合甲氨蝶呤和依那西普并未改善依那西普的疗效。

Ann Rheum Dis:早期使用TNF抑制剂有助于银屑病关节炎的缓解

在早期PsA患者中,第22周戈利木单抗+MTX的DAS缓解率几乎是单用MTX的2倍。

J Rheumatol:使用生物制剂治疗银屑病关节炎的指炎和附着点炎

汇总分析表明,抗TNF-α药物与新型药物(ustekinumab、苏金单抗和ixekizumab)在指炎和附着点炎上具有相同疗效。